Shares of Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 18 ($0.22) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.22), with a volume of 73,672 shares.
Biodexa Pharmaceuticals Price Performance
The company has a current ratio of 5.28, a quick ratio of 5.28 and a debt-to-equity ratio of 9.52. The stock has a market capitalization of £31.20 million, a PE ratio of -21.95 and a beta of 1.22. The business has a fifty day moving average price of GBX 18 and a 200-day moving average price of GBX 18.
About Biodexa Pharmaceuticals
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
Featured Articles
- Five stocks we like better than Biodexa Pharmaceuticals
- What are earnings reports?
- High-Yield Texas Instruments Could Hit New Highs Soon
- How Technical Indicators Can Help You Find Oversold Stocks
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Where Do I Find 52-Week Highs and Lows?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.